nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS2—lung cancer	0.444	1	CbGaD
Ketorolac—PTGS2—Cisplatin—lung cancer	0.0737	0.356	CbGbCtD
Ketorolac—PTGS2—Etoposide—lung cancer	0.0725	0.349	CbGbCtD
Ketorolac—PTGS1—Etoposide—lung cancer	0.0612	0.295	CbGbCtD
Ketorolac—Suprofen—UGT1A1—lung cancer	0.00111	0.185	CrCbGaD
Ketorolac—Tolmetin—CXCL8—lung cancer	0.00109	0.182	CrCbGaD
Ketorolac—Mebendazole—CYP1A1—lung cancer	0.000576	0.0957	CrCbGaD
Ketorolac—Ketoprofen—CXCL8—lung cancer	0.000534	0.0887	CrCbGaD
Ketorolac—Tiaprofenic acid—PTGS2—lung cancer	0.000404	0.0671	CrCbGaD
Ketorolac—Nepafenac—PTGS2—lung cancer	0.000384	0.0638	CrCbGaD
Ketorolac—Fenbufen—PTGS2—lung cancer	0.000367	0.0611	CrCbGaD
Ketorolac—Tolmetin—PTGS2—lung cancer	0.000319	0.0531	CrCbGaD
Ketorolac—Salsalate—PTGS2—lung cancer	0.000319	0.0531	CrCbGaD
Ketorolac—Mebendazole—ABCB1—lung cancer	0.000306	0.0509	CrCbGaD
Ketorolac—Suprofen—PTGS2—lung cancer	0.000306	0.0509	CrCbGaD
Ketorolac—Ketoprofen—PTGS2—lung cancer	0.000156	0.0259	CrCbGaD
Ketorolac—Ketoprofen—ALB—lung cancer	0.000139	0.0231	CrCbGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—MYC—lung cancer	0.000109	0.00229	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—EGFR—lung cancer	0.000107	0.00224	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.000103	0.00216	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—ALB—lung cancer	0.000103	0.00215	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—KRAS—lung cancer	0.000101	0.00212	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	0.000101	0.00211	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—CDKN2A—lung cancer	9.97e-05	0.00209	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—AZIN2—lung cancer	9.79e-05	0.00205	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—COL4A3BP—lung cancer	9.79e-05	0.00205	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—CD4—lung cancer	9.39e-05	0.00197	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	9.13e-05	0.00191	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	8.84e-05	0.00185	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—lung cancer	8.83e-05	0.00185	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	8.67e-05	0.00182	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—RB1—lung cancer	8.64e-05	0.00181	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—HRAS—lung cancer	8.59e-05	0.0018	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—CCND1—lung cancer	8.42e-05	0.00177	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ATP5H—lung cancer	8.33e-05	0.00174	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—POMC—lung cancer	8.3e-05	0.00174	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—CDKN1A—lung cancer	8.15e-05	0.00171	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	7.97e-05	0.00167	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—AZIN2—lung cancer	7.77e-05	0.00163	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—COL4A3BP—lung cancer	7.77e-05	0.00163	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—EP300—lung cancer	7.75e-05	0.00162	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	7.65e-05	0.0016	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PLBD1—lung cancer	7.42e-05	0.00155	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	7.34e-05	0.00154	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	7.3e-05	0.00153	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—NRAS—lung cancer	7.25e-05	0.00152	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	7.25e-05	0.00152	CbGpPWpGaD
Ketorolac—Photosensitivity reaction—Doxorubicin—lung cancer	7.25e-05	0.000246	CcSEcCtD
Ketorolac—Oedema—Docetaxel—lung cancer	7.23e-05	0.000245	CcSEcCtD
Ketorolac—Anaphylactic shock—Docetaxel—lung cancer	7.23e-05	0.000245	CcSEcCtD
Ketorolac—Weight increased—Doxorubicin—lung cancer	7.22e-05	0.000245	CcSEcCtD
Ketorolac—Pruritus—Gemcitabine—lung cancer	7.21e-05	0.000245	CcSEcCtD
Ketorolac—Urethral disorder—Methotrexate—lung cancer	7.19e-05	0.000244	CcSEcCtD
Ketorolac—Infection—Docetaxel—lung cancer	7.19e-05	0.000244	CcSEcCtD
Ketorolac—Feeling abnormal—Etoposide—lung cancer	7.17e-05	0.000243	CcSEcCtD
Ketorolac—Hyperglycaemia—Doxorubicin—lung cancer	7.16e-05	0.000243	CcSEcCtD
Ketorolac—Diarrhoea—Irinotecan—lung cancer	7.16e-05	0.000243	CcSEcCtD
Ketorolac—Pneumonia—Doxorubicin—lung cancer	7.12e-05	0.000241	CcSEcCtD
Ketorolac—Gastrointestinal pain—Etoposide—lung cancer	7.12e-05	0.000241	CcSEcCtD
Ketorolac—Shock—Docetaxel—lung cancer	7.12e-05	0.000241	CcSEcCtD
Ketorolac—Nervous system disorder—Docetaxel—lung cancer	7.09e-05	0.000241	CcSEcCtD
Ketorolac—Thrombocytopenia—Docetaxel—lung cancer	7.08e-05	0.00024	CcSEcCtD
Ketorolac—Drowsiness—Doxorubicin—lung cancer	7.08e-05	0.00024	CcSEcCtD
Ketorolac—Visual impairment—Methotrexate—lung cancer	7.07e-05	0.00024	CcSEcCtD
Ketorolac—Tachycardia—Docetaxel—lung cancer	7.06e-05	0.000239	CcSEcCtD
Ketorolac—Feeling abnormal—Paclitaxel—lung cancer	7.03e-05	0.000239	CcSEcCtD
Ketorolac—Skin disorder—Docetaxel—lung cancer	7.03e-05	0.000238	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	7.02e-05	0.00147	CbGpPWpGaD
Ketorolac—Stevens-Johnson syndrome—Doxorubicin—lung cancer	7.02e-05	0.000238	CcSEcCtD
Ketorolac—Hypersensitivity—Cisplatin—lung cancer	7e-05	0.000237	CcSEcCtD
Ketorolac—Gastrointestinal pain—Paclitaxel—lung cancer	6.98e-05	0.000237	CcSEcCtD
Ketorolac—Diarrhoea—Gemcitabine—lung cancer	6.97e-05	0.000237	CcSEcCtD
Ketorolac—Renal failure—Doxorubicin—lung cancer	6.96e-05	0.000236	CcSEcCtD
Ketorolac—Erythema multiforme—Methotrexate—lung cancer	6.94e-05	0.000235	CcSEcCtD
Ketorolac—Dizziness—Irinotecan—lung cancer	6.92e-05	0.000235	CcSEcCtD
Ketorolac—Urticaria—Etoposide—lung cancer	6.91e-05	0.000235	CcSEcCtD
Ketorolac—Jaundice—Doxorubicin—lung cancer	6.9e-05	0.000234	CcSEcCtD
Ketorolac—Stomatitis—Doxorubicin—lung cancer	6.9e-05	0.000234	CcSEcCtD
Ketorolac—Anorexia—Docetaxel—lung cancer	6.89e-05	0.000234	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—CXCL8—lung cancer	6.89e-05	0.00144	CbGpPWpGaD
Ketorolac—Abdominal pain—Etoposide—lung cancer	6.88e-05	0.000233	CcSEcCtD
Ketorolac—Body temperature increased—Etoposide—lung cancer	6.88e-05	0.000233	CcSEcCtD
Ketorolac—Conjunctivitis—Doxorubicin—lung cancer	6.88e-05	0.000233	CcSEcCtD
Ketorolac—Eye disorder—Methotrexate—lung cancer	6.86e-05	0.000233	CcSEcCtD
Ketorolac—Tinnitus—Methotrexate—lung cancer	6.84e-05	0.000232	CcSEcCtD
Ketorolac—Asthenia—Cisplatin—lung cancer	6.82e-05	0.000231	CcSEcCtD
Ketorolac—Cardiac disorder—Methotrexate—lung cancer	6.81e-05	0.000231	CcSEcCtD
Ketorolac—PTGS1—Metabolism—HSD17B10—lung cancer	6.79e-05	0.00142	CbGpPWpGaD
Ketorolac—Sweating—Doxorubicin—lung cancer	6.79e-05	0.00023	CcSEcCtD
Ketorolac—Urticaria—Paclitaxel—lung cancer	6.78e-05	0.00023	CcSEcCtD
Ketorolac—Hypotension—Docetaxel—lung cancer	6.76e-05	0.000229	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—MYC—lung cancer	6.76e-05	0.00142	CbGpPWpGaD
Ketorolac—Haematuria—Doxorubicin—lung cancer	6.75e-05	0.000229	CcSEcCtD
Ketorolac—Abdominal pain—Paclitaxel—lung cancer	6.75e-05	0.000229	CcSEcCtD
Ketorolac—Body temperature increased—Paclitaxel—lung cancer	6.75e-05	0.000229	CcSEcCtD
Ketorolac—Hepatobiliary disease—Doxorubicin—lung cancer	6.69e-05	0.000227	CcSEcCtD
Ketorolac—Epistaxis—Doxorubicin—lung cancer	6.68e-05	0.000226	CcSEcCtD
Ketorolac—Angiopathy—Methotrexate—lung cancer	6.66e-05	0.000226	CcSEcCtD
Ketorolac—Vomiting—Irinotecan—lung cancer	6.65e-05	0.000226	CcSEcCtD
Ketorolac—Immune system disorder—Methotrexate—lung cancer	6.63e-05	0.000225	CcSEcCtD
Ketorolac—Mediastinal disorder—Methotrexate—lung cancer	6.61e-05	0.000224	CcSEcCtD
Ketorolac—PTGS2—Metabolism—ATP5H—lung cancer	6.61e-05	0.00138	CbGpPWpGaD
Ketorolac—Agranulocytosis—Doxorubicin—lung cancer	6.6e-05	0.000224	CcSEcCtD
Ketorolac—Rash—Irinotecan—lung cancer	6.6e-05	0.000224	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—CASP3—lung cancer	6.59e-05	0.00138	CbGpPWpGaD
Ketorolac—Dermatitis—Irinotecan—lung cancer	6.59e-05	0.000224	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Docetaxel—lung cancer	6.59e-05	0.000224	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—IL2—lung cancer	6.58e-05	0.00138	CbGpPWpGaD
Ketorolac—Chills—Methotrexate—lung cancer	6.58e-05	0.000223	CcSEcCtD
Ketorolac—Headache—Irinotecan—lung cancer	6.55e-05	0.000222	CcSEcCtD
Ketorolac—Insomnia—Docetaxel—lung cancer	6.54e-05	0.000222	CcSEcCtD
Ketorolac—Diarrhoea—Cisplatin—lung cancer	6.5e-05	0.00022	CcSEcCtD
Ketorolac—Paraesthesia—Docetaxel—lung cancer	6.49e-05	0.00022	CcSEcCtD
Ketorolac—Alopecia—Methotrexate—lung cancer	6.48e-05	0.00022	CcSEcCtD
Ketorolac—Vomiting—Gemcitabine—lung cancer	6.48e-05	0.00022	CcSEcCtD
Ketorolac—Bradycardia—Doxorubicin—lung cancer	6.47e-05	0.000219	CcSEcCtD
Ketorolac—Dyspnoea—Docetaxel—lung cancer	6.45e-05	0.000219	CcSEcCtD
Ketorolac—Somnolence—Docetaxel—lung cancer	6.43e-05	0.000218	CcSEcCtD
Ketorolac—Mental disorder—Methotrexate—lung cancer	6.43e-05	0.000218	CcSEcCtD
Ketorolac—Rash—Gemcitabine—lung cancer	6.43e-05	0.000218	CcSEcCtD
Ketorolac—Dermatitis—Gemcitabine—lung cancer	6.42e-05	0.000218	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—CCND1—lung cancer	6.42e-05	0.00135	CbGpPWpGaD
Ketorolac—Hypersensitivity—Etoposide—lung cancer	6.41e-05	0.000218	CcSEcCtD
Ketorolac—Erythema—Methotrexate—lung cancer	6.39e-05	0.000217	CcSEcCtD
Ketorolac—Malnutrition—Methotrexate—lung cancer	6.39e-05	0.000217	CcSEcCtD
Ketorolac—Haemoglobin—Doxorubicin—lung cancer	6.39e-05	0.000217	CcSEcCtD
Ketorolac—Headache—Gemcitabine—lung cancer	6.38e-05	0.000217	CcSEcCtD
Ketorolac—Rhinitis—Doxorubicin—lung cancer	6.37e-05	0.000216	CcSEcCtD
Ketorolac—Dyspepsia—Docetaxel—lung cancer	6.37e-05	0.000216	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—APC—lung cancer	6.36e-05	0.00133	CbGpPWpGaD
Ketorolac—Haemorrhage—Doxorubicin—lung cancer	6.35e-05	0.000216	CcSEcCtD
Ketorolac—Hepatitis—Doxorubicin—lung cancer	6.35e-05	0.000216	CcSEcCtD
Ketorolac—PTGS1—Metabolism—CKB—lung cancer	6.31e-05	0.00132	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	6.29e-05	0.00132	CbGpPWpGaD
Ketorolac—Decreased appetite—Docetaxel—lung cancer	6.29e-05	0.000213	CcSEcCtD
Ketorolac—Hypersensitivity—Paclitaxel—lung cancer	6.29e-05	0.000213	CcSEcCtD
Ketorolac—Urinary tract disorder—Doxorubicin—lung cancer	6.27e-05	0.000213	CcSEcCtD
Ketorolac—Dysgeusia—Methotrexate—lung cancer	6.26e-05	0.000212	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Docetaxel—lung cancer	6.24e-05	0.000212	CcSEcCtD
Ketorolac—Asthenia—Etoposide—lung cancer	6.24e-05	0.000212	CcSEcCtD
Ketorolac—Connective tissue disorder—Doxorubicin—lung cancer	6.24e-05	0.000212	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—KRAS—lung cancer	6.24e-05	0.00131	CbGpPWpGaD
Ketorolac—Fatigue—Docetaxel—lung cancer	6.24e-05	0.000212	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—MMP9—lung cancer	6.23e-05	0.00131	CbGpPWpGaD
Ketorolac—Urethral disorder—Doxorubicin—lung cancer	6.23e-05	0.000211	CcSEcCtD
Ketorolac—Nausea—Irinotecan—lung cancer	6.21e-05	0.000211	CcSEcCtD
Ketorolac—Pain—Docetaxel—lung cancer	6.19e-05	0.00021	CcSEcCtD
Ketorolac—Constipation—Docetaxel—lung cancer	6.19e-05	0.00021	CcSEcCtD
Ketorolac—Back pain—Methotrexate—lung cancer	6.18e-05	0.00021	CcSEcCtD
Ketorolac—PTGS1—Selenium Micronutrient Network—IL6—lung cancer	6.16e-05	0.00129	CbGpPWpGaD
Ketorolac—Pruritus—Etoposide—lung cancer	6.16e-05	0.000209	CcSEcCtD
Ketorolac—Visual impairment—Doxorubicin—lung cancer	6.12e-05	0.000208	CcSEcCtD
Ketorolac—Asthenia—Paclitaxel—lung cancer	6.12e-05	0.000208	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	6.07e-05	0.00127	CbGpPWpGaD
Ketorolac—Nausea—Gemcitabine—lung cancer	6.05e-05	0.000205	CcSEcCtD
Ketorolac—Vomiting—Cisplatin—lung cancer	6.04e-05	0.000205	CcSEcCtD
Ketorolac—Pruritus—Paclitaxel—lung cancer	6.04e-05	0.000205	CcSEcCtD
Ketorolac—Vision blurred—Methotrexate—lung cancer	6.02e-05	0.000204	CcSEcCtD
Ketorolac—Erythema multiforme—Doxorubicin—lung cancer	6.01e-05	0.000204	CcSEcCtD
Ketorolac—Rash—Cisplatin—lung cancer	5.99e-05	0.000203	CcSEcCtD
Ketorolac—Dermatitis—Cisplatin—lung cancer	5.98e-05	0.000203	CcSEcCtD
Ketorolac—Feeling abnormal—Docetaxel—lung cancer	5.96e-05	0.000202	CcSEcCtD
Ketorolac—Diarrhoea—Etoposide—lung cancer	5.95e-05	0.000202	CcSEcCtD
Ketorolac—Eye disorder—Doxorubicin—lung cancer	5.94e-05	0.000201	CcSEcCtD
Ketorolac—PTGS1—Metabolism—CNDP2—lung cancer	5.93e-05	0.00124	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTM2—lung cancer	5.93e-05	0.00124	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	5.93e-05	0.00124	CbGpPWpGaD
Ketorolac—Ill-defined disorder—Methotrexate—lung cancer	5.93e-05	0.000201	CcSEcCtD
Ketorolac—Tinnitus—Doxorubicin—lung cancer	5.92e-05	0.000201	CcSEcCtD
Ketorolac—Gastrointestinal pain—Docetaxel—lung cancer	5.91e-05	0.000201	CcSEcCtD
Ketorolac—Anaemia—Methotrexate—lung cancer	5.9e-05	0.0002	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	5.9e-05	0.00124	CbGpPWpGaD
Ketorolac—Flushing—Doxorubicin—lung cancer	5.9e-05	0.0002	CcSEcCtD
Ketorolac—Cardiac disorder—Doxorubicin—lung cancer	5.9e-05	0.0002	CcSEcCtD
Ketorolac—PTGS2—Metabolism—PLBD1—lung cancer	5.89e-05	0.00123	CbGpPWpGaD
Ketorolac—Diarrhoea—Paclitaxel—lung cancer	5.84e-05	0.000198	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	5.79e-05	0.00121	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—MTMR3—lung cancer	5.77e-05	0.00121	CbGpPWpGaD
Ketorolac—Angiopathy—Doxorubicin—lung cancer	5.76e-05	0.000196	CcSEcCtD
Ketorolac—Malaise—Methotrexate—lung cancer	5.76e-05	0.000195	CcSEcCtD
Ketorolac—Dizziness—Etoposide—lung cancer	5.76e-05	0.000195	CcSEcCtD
Ketorolac—Immune system disorder—Doxorubicin—lung cancer	5.74e-05	0.000195	CcSEcCtD
Ketorolac—Vertigo—Methotrexate—lung cancer	5.74e-05	0.000195	CcSEcCtD
Ketorolac—Mediastinal disorder—Doxorubicin—lung cancer	5.73e-05	0.000194	CcSEcCtD
Ketorolac—Body temperature increased—Docetaxel—lung cancer	5.72e-05	0.000194	CcSEcCtD
Ketorolac—Abdominal pain—Docetaxel—lung cancer	5.72e-05	0.000194	CcSEcCtD
Ketorolac—Leukopenia—Methotrexate—lung cancer	5.72e-05	0.000194	CcSEcCtD
Ketorolac—Chills—Doxorubicin—lung cancer	5.7e-05	0.000193	CcSEcCtD
Ketorolac—Arrhythmia—Doxorubicin—lung cancer	5.68e-05	0.000193	CcSEcCtD
Ketorolac—Dizziness—Paclitaxel—lung cancer	5.64e-05	0.000191	CcSEcCtD
Ketorolac—Nausea—Cisplatin—lung cancer	5.64e-05	0.000191	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	5.63e-05	0.00118	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PGAM1—lung cancer	5.62e-05	0.00118	CbGpPWpGaD
Ketorolac—Alopecia—Doxorubicin—lung cancer	5.61e-05	0.00019	CcSEcCtD
Ketorolac—Cough—Methotrexate—lung cancer	5.57e-05	0.000189	CcSEcCtD
Ketorolac—Mental disorder—Doxorubicin—lung cancer	5.57e-05	0.000189	CcSEcCtD
Ketorolac—Convulsion—Methotrexate—lung cancer	5.53e-05	0.000188	CcSEcCtD
Ketorolac—Vomiting—Etoposide—lung cancer	5.53e-05	0.000188	CcSEcCtD
Ketorolac—Malnutrition—Doxorubicin—lung cancer	5.53e-05	0.000188	CcSEcCtD
Ketorolac—Erythema—Doxorubicin—lung cancer	5.53e-05	0.000188	CcSEcCtD
Ketorolac—Rash—Etoposide—lung cancer	5.49e-05	0.000186	CcSEcCtD
Ketorolac—Dermatitis—Etoposide—lung cancer	5.48e-05	0.000186	CcSEcCtD
Ketorolac—Headache—Etoposide—lung cancer	5.45e-05	0.000185	CcSEcCtD
Ketorolac—Flatulence—Doxorubicin—lung cancer	5.45e-05	0.000185	CcSEcCtD
Ketorolac—Chest pain—Methotrexate—lung cancer	5.44e-05	0.000184	CcSEcCtD
Ketorolac—Arthralgia—Methotrexate—lung cancer	5.44e-05	0.000184	CcSEcCtD
Ketorolac—Myalgia—Methotrexate—lung cancer	5.44e-05	0.000184	CcSEcCtD
Ketorolac—Tension—Doxorubicin—lung cancer	5.43e-05	0.000184	CcSEcCtD
Ketorolac—Vomiting—Paclitaxel—lung cancer	5.43e-05	0.000184	CcSEcCtD
Ketorolac—Dysgeusia—Doxorubicin—lung cancer	5.42e-05	0.000184	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	5.4e-05	0.000183	CcSEcCtD
Ketorolac—PTGS2—Metabolism—HSD17B10—lung cancer	5.39e-05	0.00113	CbGpPWpGaD
Ketorolac—Rash—Paclitaxel—lung cancer	5.38e-05	0.000183	CcSEcCtD
Ketorolac—Dermatitis—Paclitaxel—lung cancer	5.38e-05	0.000182	CcSEcCtD
Ketorolac—Discomfort—Methotrexate—lung cancer	5.37e-05	0.000182	CcSEcCtD
Ketorolac—Nervousness—Doxorubicin—lung cancer	5.37e-05	0.000182	CcSEcCtD
Ketorolac—PTGS1—Metabolism—CYP2A7—lung cancer	5.36e-05	0.00112	CbGpPWpGaD
Ketorolac—Back pain—Doxorubicin—lung cancer	5.35e-05	0.000181	CcSEcCtD
Ketorolac—Headache—Paclitaxel—lung cancer	5.35e-05	0.000181	CcSEcCtD
Ketorolac—PTGS2—Disease—PGAM1—lung cancer	5.33e-05	0.00112	CbGpPWpGaD
Ketorolac—Hypersensitivity—Docetaxel—lung cancer	5.33e-05	0.000181	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—HRAS—lung cancer	5.31e-05	0.00111	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—MAPK3—lung cancer	5.29e-05	0.00111	CbGpPWpGaD
Ketorolac—Confusional state—Methotrexate—lung cancer	5.26e-05	0.000178	CcSEcCtD
Ketorolac—PTGS1—Metabolism—SDC4—lung cancer	5.25e-05	0.0011	CbGpPWpGaD
Ketorolac—Anaphylactic shock—Methotrexate—lung cancer	5.21e-05	0.000177	CcSEcCtD
Ketorolac—Vision blurred—Doxorubicin—lung cancer	5.21e-05	0.000177	CcSEcCtD
Ketorolac—Asthenia—Docetaxel—lung cancer	5.19e-05	0.000176	CcSEcCtD
Ketorolac—Infection—Methotrexate—lung cancer	5.18e-05	0.000176	CcSEcCtD
Ketorolac—Nausea—Etoposide—lung cancer	5.17e-05	0.000175	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—MYC—lung cancer	5.15e-05	0.00108	CbGpPWpGaD
Ketorolac—Ill-defined disorder—Doxorubicin—lung cancer	5.13e-05	0.000174	CcSEcCtD
Ketorolac—Pruritus—Docetaxel—lung cancer	5.12e-05	0.000174	CcSEcCtD
Ketorolac—Nervous system disorder—Methotrexate—lung cancer	5.11e-05	0.000173	CcSEcCtD
Ketorolac—Anaemia—Doxorubicin—lung cancer	5.11e-05	0.000173	CcSEcCtD
Ketorolac—Thrombocytopenia—Methotrexate—lung cancer	5.1e-05	0.000173	CcSEcCtD
Ketorolac—Agitation—Doxorubicin—lung cancer	5.08e-05	0.000172	CcSEcCtD
Ketorolac—Nausea—Paclitaxel—lung cancer	5.07e-05	0.000172	CcSEcCtD
Ketorolac—Skin disorder—Methotrexate—lung cancer	5.06e-05	0.000172	CcSEcCtD
Ketorolac—Hyperhidrosis—Methotrexate—lung cancer	5.04e-05	0.000171	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—EGFR—lung cancer	5.04e-05	0.00106	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	5.01e-05	0.00105	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CKB—lung cancer	5.01e-05	0.00105	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	5e-05	0.00105	CbGpPWpGaD
Ketorolac—Malaise—Doxorubicin—lung cancer	4.99e-05	0.000169	CcSEcCtD
Ketorolac—PTGS2—Disease—SDC4—lung cancer	4.98e-05	0.00104	CbGpPWpGaD
Ketorolac—Vertigo—Doxorubicin—lung cancer	4.97e-05	0.000169	CcSEcCtD
Ketorolac—Anorexia—Methotrexate—lung cancer	4.97e-05	0.000169	CcSEcCtD
Ketorolac—Syncope—Doxorubicin—lung cancer	4.96e-05	0.000168	CcSEcCtD
Ketorolac—Leukopenia—Doxorubicin—lung cancer	4.95e-05	0.000168	CcSEcCtD
Ketorolac—Diarrhoea—Docetaxel—lung cancer	4.95e-05	0.000168	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	4.94e-05	0.00104	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—IL6—lung cancer	4.89e-05	0.00103	CbGpPWpGaD
Ketorolac—Palpitations—Doxorubicin—lung cancer	4.89e-05	0.000166	CcSEcCtD
Ketorolac—Hypotension—Methotrexate—lung cancer	4.87e-05	0.000165	CcSEcCtD
Ketorolac—Loss of consciousness—Doxorubicin—lung cancer	4.86e-05	0.000165	CcSEcCtD
Ketorolac—Cough—Doxorubicin—lung cancer	4.83e-05	0.000164	CcSEcCtD
Ketorolac—Convulsion—Doxorubicin—lung cancer	4.79e-05	0.000163	CcSEcCtD
Ketorolac—Dizziness—Docetaxel—lung cancer	4.78e-05	0.000162	CcSEcCtD
Ketorolac—PTGS1—Metabolism—RRM1—lung cancer	4.78e-05	0.001	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTA3—lung cancer	4.78e-05	0.001	CbGpPWpGaD
Ketorolac—Hypertension—Doxorubicin—lung cancer	4.78e-05	0.000162	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Methotrexate—lung cancer	4.75e-05	0.000161	CcSEcCtD
Ketorolac—Insomnia—Methotrexate—lung cancer	4.71e-05	0.00016	CcSEcCtD
Ketorolac—PTGS2—Metabolism—GSTM2—lung cancer	4.71e-05	0.000987	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CNDP2—lung cancer	4.71e-05	0.000987	CbGpPWpGaD
Ketorolac—Arthralgia—Doxorubicin—lung cancer	4.71e-05	0.00016	CcSEcCtD
Ketorolac—Chest pain—Doxorubicin—lung cancer	4.71e-05	0.00016	CcSEcCtD
Ketorolac—Myalgia—Doxorubicin—lung cancer	4.71e-05	0.00016	CcSEcCtD
Ketorolac—Anxiety—Doxorubicin—lung cancer	4.69e-05	0.000159	CcSEcCtD
Ketorolac—Paraesthesia—Methotrexate—lung cancer	4.68e-05	0.000159	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	4.68e-05	0.000159	CcSEcCtD
Ketorolac—Discomfort—Doxorubicin—lung cancer	4.65e-05	0.000158	CcSEcCtD
Ketorolac—Dyspnoea—Methotrexate—lung cancer	4.65e-05	0.000158	CcSEcCtD
Ketorolac—Somnolence—Methotrexate—lung cancer	4.63e-05	0.000157	CcSEcCtD
Ketorolac—Dry mouth—Doxorubicin—lung cancer	4.61e-05	0.000156	CcSEcCtD
Ketorolac—Vomiting—Docetaxel—lung cancer	4.6e-05	0.000156	CcSEcCtD
Ketorolac—Dyspepsia—Methotrexate—lung cancer	4.59e-05	0.000156	CcSEcCtD
Ketorolac—PTGS2—Metabolism—MTMR3—lung cancer	4.58e-05	0.00096	CbGpPWpGaD
Ketorolac—Rash—Docetaxel—lung cancer	4.56e-05	0.000155	CcSEcCtD
Ketorolac—Dermatitis—Docetaxel—lung cancer	4.56e-05	0.000155	CcSEcCtD
Ketorolac—Confusional state—Doxorubicin—lung cancer	4.55e-05	0.000154	CcSEcCtD
Ketorolac—Decreased appetite—Methotrexate—lung cancer	4.53e-05	0.000154	CcSEcCtD
Ketorolac—Headache—Docetaxel—lung cancer	4.53e-05	0.000154	CcSEcCtD
Ketorolac—Oedema—Doxorubicin—lung cancer	4.51e-05	0.000153	CcSEcCtD
Ketorolac—Anaphylactic shock—Doxorubicin—lung cancer	4.51e-05	0.000153	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Methotrexate—lung cancer	4.5e-05	0.000153	CcSEcCtD
Ketorolac—PTGS1—Metabolism—B4GALT5—lung cancer	4.5e-05	0.000942	CbGpPWpGaD
Ketorolac—Fatigue—Methotrexate—lung cancer	4.49e-05	0.000152	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	4.49e-05	0.00094	CbGpPWpGaD
Ketorolac—Infection—Doxorubicin—lung cancer	4.48e-05	0.000152	CcSEcCtD
Ketorolac—PTGS2—Metabolism—PGAM1—lung cancer	4.46e-05	0.000935	CbGpPWpGaD
Ketorolac—Pain—Methotrexate—lung cancer	4.46e-05	0.000151	CcSEcCtD
Ketorolac—Shock—Doxorubicin—lung cancer	4.44e-05	0.000151	CcSEcCtD
Ketorolac—Nervous system disorder—Doxorubicin—lung cancer	4.43e-05	0.00015	CcSEcCtD
Ketorolac—Thrombocytopenia—Doxorubicin—lung cancer	4.42e-05	0.00015	CcSEcCtD
Ketorolac—Tachycardia—Doxorubicin—lung cancer	4.41e-05	0.000149	CcSEcCtD
Ketorolac—PTGS2—Disease—SKI—lung cancer	4.39e-05	0.00092	CbGpPWpGaD
Ketorolac—Skin disorder—Doxorubicin—lung cancer	4.38e-05	0.000149	CcSEcCtD
Ketorolac—PTGS1—Metabolism—GSTA4—lung cancer	4.37e-05	0.000916	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	4.37e-05	0.000915	CbGpPWpGaD
Ketorolac—Hyperhidrosis—Doxorubicin—lung cancer	4.36e-05	0.000148	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	4.36e-05	0.000913	CbGpPWpGaD
Ketorolac—Anorexia—Doxorubicin—lung cancer	4.3e-05	0.000146	CcSEcCtD
Ketorolac—Nausea—Docetaxel—lung cancer	4.3e-05	0.000146	CcSEcCtD
Ketorolac—Feeling abnormal—Methotrexate—lung cancer	4.3e-05	0.000146	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	4.27e-05	0.000896	CbGpPWpGaD
Ketorolac—Gastrointestinal pain—Methotrexate—lung cancer	4.26e-05	0.000145	CcSEcCtD
Ketorolac—PTGS1—Metabolism—GSTA2—lung cancer	4.26e-05	0.000893	CbGpPWpGaD
Ketorolac—PTGS2—Disease—B4GALT5—lung cancer	4.26e-05	0.000893	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP2A7—lung cancer	4.26e-05	0.000892	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TP53—lung cancer	4.23e-05	0.000886	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	4.22e-05	0.000885	CbGpPWpGaD
Ketorolac—Hypotension—Doxorubicin—lung cancer	4.22e-05	0.000143	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	4.21e-05	0.000883	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SDC4—lung cancer	4.17e-05	0.000873	CbGpPWpGaD
Ketorolac—Urticaria—Methotrexate—lung cancer	4.14e-05	0.00014	CcSEcCtD
Ketorolac—Abdominal pain—Methotrexate—lung cancer	4.12e-05	0.00014	CcSEcCtD
Ketorolac—Body temperature increased—Methotrexate—lung cancer	4.12e-05	0.00014	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Doxorubicin—lung cancer	4.11e-05	0.00014	CcSEcCtD
Ketorolac—PTGS1—Metabolism—GSTA1—lung cancer	4.11e-05	0.000862	CbGpPWpGaD
Ketorolac—Insomnia—Doxorubicin—lung cancer	4.08e-05	0.000138	CcSEcCtD
Ketorolac—PTGS1—Metabolism—ABCC3—lung cancer	4.07e-05	0.000852	CbGpPWpGaD
Ketorolac—Paraesthesia—Doxorubicin—lung cancer	4.05e-05	0.000138	CcSEcCtD
Ketorolac—Dyspnoea—Doxorubicin—lung cancer	4.02e-05	0.000137	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	4.02e-05	0.000842	CbGpPWpGaD
Ketorolac—Somnolence—Doxorubicin—lung cancer	4.01e-05	0.000136	CcSEcCtD
Ketorolac—Dyspepsia—Doxorubicin—lung cancer	3.97e-05	0.000135	CcSEcCtD
Ketorolac—PTGS1—Metabolism—AKR1C1—lung cancer	3.94e-05	0.000825	CbGpPWpGaD
Ketorolac—Decreased appetite—Doxorubicin—lung cancer	3.92e-05	0.000133	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	3.91e-05	0.000819	CbGpPWpGaD
Ketorolac—Gastrointestinal disorder—Doxorubicin—lung cancer	3.9e-05	0.000132	CcSEcCtD
Ketorolac—Fatigue—Doxorubicin—lung cancer	3.89e-05	0.000132	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—IL6—lung cancer	3.87e-05	0.000811	CbGpPWpGaD
Ketorolac—Pain—Doxorubicin—lung cancer	3.86e-05	0.000131	CcSEcCtD
Ketorolac—Constipation—Doxorubicin—lung cancer	3.86e-05	0.000131	CcSEcCtD
Ketorolac—Hypersensitivity—Methotrexate—lung cancer	3.84e-05	0.00013	CcSEcCtD
Ketorolac—PTGS1—Metabolism—UGT1A1—lung cancer	3.82e-05	0.000801	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PXN—lung cancer	3.81e-05	0.000799	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	3.81e-05	0.000798	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—RRM1—lung cancer	3.8e-05	0.000795	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTA3—lung cancer	3.8e-05	0.000795	CbGpPWpGaD
Ketorolac—Asthenia—Methotrexate—lung cancer	3.74e-05	0.000127	CcSEcCtD
Ketorolac—PTGS2—Disease—AKR1C1—lung cancer	3.73e-05	0.000782	CbGpPWpGaD
Ketorolac—Feeling abnormal—Doxorubicin—lung cancer	3.72e-05	0.000126	CcSEcCtD
Ketorolac—Gastrointestinal pain—Doxorubicin—lung cancer	3.69e-05	0.000125	CcSEcCtD
Ketorolac—Pruritus—Methotrexate—lung cancer	3.69e-05	0.000125	CcSEcCtD
Ketorolac—PTGS1—Metabolism—GNG11—lung cancer	3.69e-05	0.000772	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.67e-05	0.000768	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	3.6e-05	0.000755	CbGpPWpGaD
Ketorolac—Urticaria—Doxorubicin—lung cancer	3.59e-05	0.000122	CcSEcCtD
Ketorolac—PTGS2—Metabolism—B4GALT5—lung cancer	3.57e-05	0.000748	CbGpPWpGaD
Ketorolac—Body temperature increased—Doxorubicin—lung cancer	3.57e-05	0.000121	CcSEcCtD
Ketorolac—Abdominal pain—Doxorubicin—lung cancer	3.57e-05	0.000121	CcSEcCtD
Ketorolac—Diarrhoea—Methotrexate—lung cancer	3.57e-05	0.000121	CcSEcCtD
Ketorolac—PTGS1—Metabolism—ALDOA—lung cancer	3.51e-05	0.000735	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	3.5e-05	0.000734	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTA4—lung cancer	3.47e-05	0.000728	CbGpPWpGaD
Ketorolac—Dizziness—Methotrexate—lung cancer	3.45e-05	0.000117	CcSEcCtD
Ketorolac—PTGS2—Disease—NPPA—lung cancer	3.44e-05	0.00072	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	3.43e-05	0.000718	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NCOA3—lung cancer	3.41e-05	0.000714	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	3.39e-05	0.000711	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTA2—lung cancer	3.38e-05	0.000709	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PPIA—lung cancer	3.35e-05	0.000703	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.35e-05	0.000702	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ALDOA—lung cancer	3.33e-05	0.000697	CbGpPWpGaD
Ketorolac—Hypersensitivity—Doxorubicin—lung cancer	3.33e-05	0.000113	CcSEcCtD
Ketorolac—Vomiting—Methotrexate—lung cancer	3.31e-05	0.000112	CcSEcCtD
Ketorolac—PTGS1—Metabolism—ABCG2—lung cancer	3.31e-05	0.000695	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ADCY1—lung cancer	3.31e-05	0.000695	CbGpPWpGaD
Ketorolac—Rash—Methotrexate—lung cancer	3.29e-05	0.000112	CcSEcCtD
Ketorolac—Dermatitis—Methotrexate—lung cancer	3.28e-05	0.000111	CcSEcCtD
Ketorolac—Headache—Methotrexate—lung cancer	3.27e-05	0.000111	CcSEcCtD
Ketorolac—PTGS2—Metabolism—GSTA1—lung cancer	3.26e-05	0.000684	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ENO2—lung cancer	3.25e-05	0.000681	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—HPGDS—lung cancer	3.25e-05	0.000681	CbGpPWpGaD
Ketorolac—Asthenia—Doxorubicin—lung cancer	3.24e-05	0.00011	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	3.24e-05	0.000678	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PPP2R1B—lung cancer	3.23e-05	0.000677	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ABCC3—lung cancer	3.23e-05	0.000676	CbGpPWpGaD
Ketorolac—Pruritus—Doxorubicin—lung cancer	3.19e-05	0.000108	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.19e-05	0.000668	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTT1—lung cancer	3.15e-05	0.000661	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ADCY1—lung cancer	3.14e-05	0.000658	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—AKR1C1—lung cancer	3.13e-05	0.000655	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GCLC—lung cancer	3.12e-05	0.000653	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP2A6—lung cancer	3.12e-05	0.000653	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.1e-05	0.00065	CbGpPWpGaD
Ketorolac—Nausea—Methotrexate—lung cancer	3.1e-05	0.000105	CcSEcCtD
Ketorolac—Diarrhoea—Doxorubicin—lung cancer	3.09e-05	0.000105	CcSEcCtD
Ketorolac—PTGS2—Disease—ENO2—lung cancer	3.08e-05	0.000646	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SMARCA4—lung cancer	3.06e-05	0.000642	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PPP2R1B—lung cancer	3.06e-05	0.000642	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—UGT1A1—lung cancer	3.03e-05	0.000636	CbGpPWpGaD
Ketorolac—Dizziness—Doxorubicin—lung cancer	2.98e-05	0.000101	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	2.97e-05	0.000623	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ENO1—lung cancer	2.95e-05	0.000619	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.94e-05	0.000617	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GNG11—lung cancer	2.93e-05	0.000613	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.91e-05	0.00061	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.91e-05	0.000609	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	2.88e-05	0.000603	CbGpPWpGaD
Ketorolac—Vomiting—Doxorubicin—lung cancer	2.87e-05	9.74e-05	CcSEcCtD
Ketorolac—Rash—Doxorubicin—lung cancer	2.85e-05	9.66e-05	CcSEcCtD
Ketorolac—Dermatitis—Doxorubicin—lung cancer	2.84e-05	9.65e-05	CcSEcCtD
Ketorolac—Headache—Doxorubicin—lung cancer	2.83e-05	9.59e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—ENO1—lung cancer	2.8e-05	0.000587	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ALDOA—lung cancer	2.79e-05	0.000584	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NCOA3—lung cancer	2.7e-05	0.000567	CbGpPWpGaD
Ketorolac—Nausea—Doxorubicin—lung cancer	2.68e-05	9.1e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.66e-05	0.000557	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP2E1—lung cancer	2.65e-05	0.000555	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ADCY1—lung cancer	2.63e-05	0.000551	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ABCG2—lung cancer	2.63e-05	0.000551	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NQO1—lung cancer	2.62e-05	0.000549	CbGpPWpGaD
Ketorolac—PTGS2—Disease—APP—lung cancer	2.6e-05	0.000546	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FGF9—lung cancer	2.58e-05	0.000541	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—HPGDS—lung cancer	2.58e-05	0.000541	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ENO2—lung cancer	2.58e-05	0.000541	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.57e-05	0.000538	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PPP2R1B—lung cancer	2.56e-05	0.000537	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.54e-05	0.000533	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.53e-05	0.00053	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTT1—lung cancer	2.5e-05	0.000524	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GCLC—lung cancer	2.47e-05	0.000518	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP2A6—lung cancer	2.47e-05	0.000518	CbGpPWpGaD
Ketorolac—PTGS2—Disease—JUNB—lung cancer	2.47e-05	0.000517	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.46e-05	0.000516	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	2.43e-05	0.000509	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—STK11—lung cancer	2.36e-05	0.000495	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ENO1—lung cancer	2.35e-05	0.000491	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.34e-05	0.00049	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.31e-05	0.000483	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.22e-05	0.000465	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTP1—lung cancer	2.19e-05	0.000458	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FOXO3—lung cancer	2.16e-05	0.000453	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CAT—lung cancer	2.13e-05	0.000446	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.11e-05	0.000443	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP2E1—lung cancer	2.1e-05	0.000441	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NQO1—lung cancer	2.08e-05	0.000436	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ABCB1—lung cancer	2.07e-05	0.000433	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.04e-05	0.000427	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—TYMS—lung cancer	2.03e-05	0.000426	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTM1—lung cancer	2.01e-05	0.000421	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HES1—lung cancer	1.91e-05	0.000401	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP1A1—lung cancer	1.9e-05	0.000399	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ERCC2—lung cancer	1.89e-05	0.000396	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—STK11—lung cancer	1.87e-05	0.000393	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ERCC2—lung cancer	1.79e-05	0.000375	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.76e-05	0.000369	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ERBB3—lung cancer	1.75e-05	0.000367	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTP1—lung cancer	1.73e-05	0.000364	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CAT—lung cancer	1.69e-05	0.000354	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.68e-05	0.000352	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TERT—lung cancer	1.68e-05	0.000352	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ABCB1—lung cancer	1.64e-05	0.000344	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—APOA1—lung cancer	1.63e-05	0.000342	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FGFR1—lung cancer	1.63e-05	0.000341	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—TYMS—lung cancer	1.61e-05	0.000338	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HIF1A—lung cancer	1.6e-05	0.000336	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTM1—lung cancer	1.59e-05	0.000334	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.56e-05	0.000328	CbGpPWpGaD
Ketorolac—PTGS2—Disease—APOA1—lung cancer	1.55e-05	0.000324	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP1A1—lung cancer	1.51e-05	0.000317	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ERCC2—lung cancer	1.5e-05	0.000314	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CG—lung cancer	1.49e-05	0.000312	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—POMC—lung cancer	1.42e-05	0.000297	CbGpPWpGaD
Ketorolac—PTGS2—Disease—KIT—lung cancer	1.41e-05	0.000296	CbGpPWpGaD
Ketorolac—PTGS2—Disease—APC—lung cancer	1.41e-05	0.000296	CbGpPWpGaD
Ketorolac—PTGS2—Disease—EGF—lung cancer	1.4e-05	0.000293	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CREBBP—lung cancer	1.38e-05	0.00029	CbGpPWpGaD
Ketorolac—PTGS2—Disease—BRAF—lung cancer	1.33e-05	0.000278	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IL6R—lung cancer	1.31e-05	0.000275	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CD—lung cancer	1.31e-05	0.000275	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CREBBP—lung cancer	1.31e-05	0.000275	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—APOA1—lung cancer	1.3e-05	0.000272	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ALB—lung cancer	1.29e-05	0.000271	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MAP2K1—lung cancer	1.25e-05	0.000262	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PIK3CD—lung cancer	1.24e-05	0.00026	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.24e-05	0.00026	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CG—lung cancer	1.18e-05	0.000248	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CB—lung cancer	1.14e-05	0.000239	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PTGS2—lung cancer	1.13e-05	0.000237	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—POMC—lung cancer	1.13e-05	0.000236	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MDM2—lung cancer	1.11e-05	0.000233	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RAF1—lung cancer	1.11e-05	0.000232	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CREBBP—lung cancer	1.1e-05	0.00023	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ERBB2—lung cancer	1.1e-05	0.00023	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PIK3CB—lung cancer	1.08e-05	0.000227	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MTOR—lung cancer	1.08e-05	0.000227	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CD4—lung cancer	1.08e-05	0.000227	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CD—lung cancer	1.04e-05	0.000218	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ALB—lung cancer	1.03e-05	0.000215	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PTEN—lung cancer	9.87e-06	0.000207	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—EP300—lung cancer	9.42e-06	0.000197	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CDKN1A—lung cancer	9.38e-06	0.000197	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PTEN—lung cancer	9.36e-06	0.000196	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CB—lung cancer	9.07e-06	0.00019	CbGpPWpGaD
Ketorolac—PTGS2—Disease—EP300—lung cancer	8.92e-06	0.000187	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SRC—lung cancer	8.68e-06	0.000182	CbGpPWpGaD
Ketorolac—PTGS2—Disease—STAT3—lung cancer	8.37e-06	0.000175	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NRAS—lung cancer	8.35e-06	0.000175	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MAPK3—lung cancer	8e-06	0.000168	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PTEN—lung cancer	7.84e-06	0.000164	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MYC—lung cancer	7.78e-06	0.000163	CbGpPWpGaD
Ketorolac—PTGS2—Disease—EGFR—lung cancer	7.61e-06	0.000159	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—EP300—lung cancer	7.47e-06	0.000157	CbGpPWpGaD
Ketorolac—PTGS2—Disease—KRAS—lung cancer	7.19e-06	0.000151	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CA—lung cancer	6.96e-06	0.000146	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PIK3CA—lung cancer	6.6e-06	0.000138	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HRAS—lung cancer	6.11e-06	0.000128	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IL6—lung cancer	5.85e-06	0.000123	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—AKT1—lung cancer	5.69e-06	0.000119	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CA—lung cancer	5.53e-06	0.000116	CbGpPWpGaD
Ketorolac—PTGS2—Disease—AKT1—lung cancer	5.39e-06	0.000113	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—AKT1—lung cancer	4.52e-06	9.46e-05	CbGpPWpGaD
